2011Heilongjiang yiyao kexueRequires access

Ziprasidone and risperidone in the treatment of schizophrenia:A comparative study

Yin Jun-bo

Open publisher page 0 citations

Abstract

Objective: To compare the efficacy and safety of ziprasidone and resperidone in the treatment of schizophrenia.Methods: Sixty-four patients with schizophrenia were randomly assigned as two groups treated with ziprasidone or risperidone for 8 weeks.The positive and negative symptom scale(PANSS) and treatment emergent symptoms scale(TESS)were used t o evaluate the efficacy and adverse effects before and at the end of 2,4,8 weeks of treatment.Results:The total effective rates of ziprasidone and risperidone were 81.2% and 84.3% respectively after 8-week treatments.There was no significant difference between two groups(P0.05).The patients treated with ziprasidone showed fewer side effects including weight gain,Extra Pyramidal Symptoms(EPS) and menses change than the patients with risperidone.Conclusion: Ziprasidone is effective in the treatment of schizophrenia,specifically improving negative symptoms.Ziprasidone has fewer side effects compared with risperidone.

About this research paper

What this paper is about

Objective: To compare the efficacy and safety of ziprasidone and resperidone in the treatment of schizophrenia.Methods: Sixty-four patients with schizophrenia were randomly assigned as two groups treated with ziprasidone or risperidone for 8 weeks.The positive and negative symptom scale(PANSS) and treatment emergent symptoms scale(TESS)were used t o evaluate the efficacy and adverse effects before and at the end of 2,4,8 weeks of treatment.Results:The total effective rates of ziprasidone and risperidone were 81.2% and 84.3% respectively after 8-week treatments.There was no significant difference between two groups(P0.05).The patients treated with ziprasidone showed fewer side effects including weight gain,Extra Pyramidal Symptoms(EPS) and menses change than the patients with risperidone.Conclusion: Ziprasidone is effective in the treatment of schizophrenia,specifically improving negative symptoms.Ziprasidone has fewer side effects compared with risperidone.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To compare the efficacy and safety of ziprasidone and resperidone in the treatment of schizophrenia.Methods: Sixty-four patients with schizophrenia were randomly assigned as two groups treated with ziprasidone or risperidone for 8 weeks.The positive and negative symptom scale(PANSS) and treatment emergent symptoms scale(TESS)were used t o evaluate the efficacy and adverse effects before and at the end of 2,4,8 weeks of treatment.Results:The total effective rates of ziprasidone and risperidone were 81.2% and 84.3% respectively after 8-week treatments.There was no significant difference between two groups(P0.05).The patients treated with ziprasidone showed fewer side effects including weight gain,Extra Pyramidal Symptoms(EPS) and menses change than the patients with risperidone.Conclusion: Ziprasidone is effective in the treatment of schizophrenia,specifically improving negative symptoms.Ziprasidone has fewer side effects compared with risperidone.

Key concepts: Ziprasidone, Risperidone, Schizophrenia (object-oriented programming), Negative symptom, Significant difference, Medicine, Internal medicine, Adverse effect

Related papers

Back to paper searchBrowse research topicsOriginal source
Ziprasidone and risperidone in the treatment of schizophrenia:A comparative study — Research Paper | ScholarLens